• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Comput Biol . Alignment-free prediction of cross-reactivity in influenza A (H3N2) anticipates antigenic drift

tetano

Editor, Senior Moderator
PLoS Comput Biol


. 2026 Aug 11;22(8):e1014628.
doi: 10.1371/journal.pcbi.1014628. Online ahead of print.
Alignment-free prediction of cross-reactivity in influenza A (H3N2) anticipates antigenic drift

Alpha Forna[SUP] 1 2 3 [/SUP], Lambodhar Damodaran[SUP] 4 5 [/SUP], Christian E Gunning[SUP] 1 2 [/SUP], Parnian Rahimi[SUP] 5 6 [/SUP], Aarya Venkat[SUP] 5 [/SUP], Natarajan Kannan[SUP] 5 [/SUP], Rebecca Kondor[SUP] 7 [/SUP], Justin Bahl[SUP] 2 6 [/SUP], Pejman Rohani[SUP] 1 2 6 8 [/SUP], John M Drake[SUP] 1 2 5 6 [/SUP]


Affiliations
Abstract

Since its introduction in 1968, Influenza A (H3N2) has undergone continuous antigenic evolution, necessitating frequent vaccine updates. To predict antigenicity and characterize antigenic drift without multiple sequence alignments, we present FluEmbed, a computational framework that leverages protein language models. FluEmbed accurately quantified the antigenic impact of viral evolution from RNA sequences, achieving strong predictive performance against hemagglutination inhibition (HI) assay titers (Spearman correlation: ρ = 0.67-0.80). FluEmbed also outperformed sequence-distance baselines (e.g., Hamming and BLOSUM62) and phylogenetic tree-based models that require sequence alignment. Using this model, we conducted in-silico mutagenesis experiments to identify site/amino acid combinations that differentially impacted antigenicity. To systematically investigate how specific mutations influence immune escape, we defined two classes of mutations: 'constrained', where only the most likely amino acid changes at historically mutation-prone sites were considered (thereby limiting the mutation space) and 'unconstrained', where all possible substitutions were allowed, providing a full exploration of potential antigenic shifts. Constrained mutations often confer limited antigenic changes, whereas unconstrained mutations exhibit greater escape potential, particularly outside the dominant viral lineages. Notably, 3C.2a was the only major lineage in which constrained and unconstrained mutations showed no significant difference (p ≈ 0.9), suggesting ongoing intra-clade competition rather than inter-lineage antigenic replacement. By enabling rapid, alignment-free antigenic prediction directly from sequence data, FluEmbed could complement traditional HI assays in real-time influenza surveillance and inform vaccine strain selection decisions.


 
Back
Top